Immuno-Oncology News

November 15, 2019November 15, 2019

Treatment With VBI-1901 Linked to Tumor Stabilization in Recurrent Gliobastoma Patients in Phase 1/2 Trial

This post was originally published on this siteThis post was originally published on this site Immune responses triggered by the investigational cancer vaccine ... Read more

November 13, 2019November 13, 2019

CytomX Initiates Phase 2 Trial Testing CX-072, Yervoy Combo in Relapsed or Refractory Melanoma

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site CytomX Therapeutics has initiated a Phase 2 clinical ... Read more

November 11, 2019November 12, 2019

2 Imfinzi Combos Delay Cancer Progression in Metastatic NSCLC, Interim Phase 3 Data Show

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Adding Imfinzi (durvalumab) — alone or in combination with tremelimumab ... Read more

November 8, 2019November 8, 2019

MDNA55 Increases Survival in Glioblastoma, Notably in Patients With High ILR4 Levels, Early Trial Data Show

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site The investigational therapy MDNA55 increases survival in people ... Read more

November 6, 2019November 6, 2019

Opdivo-Yervoy Plus Shorter Chemotherapy Course Extends Survival of Patients with Advanced Lung Cancer, Early Trial Data Show

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site First-line treatment with a combination of Opdivo (nivolumab) ... Read more

November 4, 2019November 4, 2019

Tecentriq-Avastin Prolongs Life of Patients with Advanced Liver Cancer in Trial, Roche Reports

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site A combination of Tecentriq (atezolizumab) and Avastin (bevacizumab) ... Read more

October 30, 2019October 30, 2019

European Commission Approves Bavencio-Inlyta for First-line Treatment of Advanced Kidney Cancer

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site The European Commission (EC) has approved a combination ... Read more

October 28, 2019October 28, 2019

Keytruda Survival Benefits Similar to Chemo for Relapsed Mesothelioma, Phase 3 Trial Finds

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Treatment with the immunotherapy Keytruda (pembrolizumab) appears to ... Read more

October 25, 2019October 25, 2019

Blincyto Increases Survival of ALL Children, Adolescents After First Relapse, Phase 3 Trials Show

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Blincyto (blinatumomab) increases overall survival and disease-free survival ... Read more

October 23, 2019October 23, 2019

CHMP Favors Keytruda Regimens to Treat Recurrent Head and Neck Cancers

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site The Committee for Medicinal Products for Human Use ... Read more